MOESM3 of Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
收藏数据链接：
官方服务：
资源简介：
Additional file 3: Tumor Microarray Patient Characteristics (H3K9me2 staining and Kaplan-Meier analysis includes only 92 primary tumors prior to therapy).
创建时间：
2019-11-27
